GSK buys rights to Hansoh Pharma antibody-drug conjugate - ShareCast
| 3KY Stock | EUR 2.16 0.06 2.70% |
Roughly 61% of HANSOH PHARMAC's investor base is looking to short. The analysis of current outlook of investing in HANSOH PHARMAC HD 00001 suggests that many traders are alarmed regarding HANSOH PHARMAC's prospects. The current market sentiment, together with HANSOH PHARMAC's historical and current headlines, can help investors time the market. In addition, many technical investors use HANSOH PHARMAC HD stock news signals to limit their universe of possible portfolio assets.
HANSOH PHARMAC stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of HANSOH daily returns and investor perception about the current price of HANSOH PHARMAC HD 00001 as well as its diversification or hedging effects on your existing portfolios.
HANSOH |
GSK buys rights to Hansoh Pharma antibody-drug conjugate ShareCast
Read at news.google.com
 |
HANSOH PHARMAC Fundamental Analysis
We analyze HANSOH PHARMAC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HANSOH PHARMAC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HANSOH PHARMAC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
HANSOH PHARMAC is rated below average in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
HANSOH PHARMAC HD Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with HANSOH PHARMAC stock to make a market-neutral strategy. Peer analysis of HANSOH PHARMAC could also be used in its relative valuation, which is a method of valuing HANSOH PHARMAC by comparing valuation metrics with similar companies.
Peers
HANSOH PHARMAC Related Equities
| GU5 | Guangzhou Baiyunshan | 1.90 | ||||
| HPX | Hisamitsu Pharmaceutical | 0.80 | ||||
| 5EA | Elanco Animal | 0.53 | ||||
| TSUA | Tsumura | 0.00 | ||||
| CJH | CanSino Biologics | 0.54 | ||||
| TKDA | Takeda Pharmaceutical | 0.81 | ||||
| MRK | Merck | 1.16 | ||||
| LDZU | ASPEN PHARUNADR | 1.16 | ||||
| 3KY | HANSOH PHARMAC | 2.70 |
Complementary Tools for HANSOH Stock analysis
When running HANSOH PHARMAC's price analysis, check to measure HANSOH PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HANSOH PHARMAC is operating at the current time. Most of HANSOH PHARMAC's value examination focuses on studying past and present price action to predict the probability of HANSOH PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HANSOH PHARMAC's price. Additionally, you may evaluate how the addition of HANSOH PHARMAC to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |